Stanford Health Care-Sponsored Stanford University Dermatopathology (Multidisciplinary)

Topics

• Cutaneous Melanoma Detection and Management 208
• Cutaneous lymphoproliferative disorders research 120
• Cancer Immunotherapy and Biomarkers 99
• Cancer and Skin Lesions 71
• Nonmelanoma Skin Cancer Studies 49
• Sarcoma Diagnosis and Treatment 46
• Viral-associated cancers and disorders 26
• Vascular Tumors and Angiosarcomas 25
• Histiocytic Disorders and Treatments 24
• Polyomavirus and related diseases 24
• Psoriasis: Treatment and Pathogenesis 21
• Autoimmune and Inflammatory Disorders 19

Most cited

1. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.

   The New England journal of medicine · 2022 · 2,432 citations · Janis Taube

2. Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.

   The New England journal of medicine · 2023 · 710 citations · Janis Taube

3. Perioperative Nivolumab in Resectable Lung Cancer.

   The New England journal of medicine · 2024 · 495 citations · Janis Taube

4. Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.

   The New England journal of medicine · 2025 · 201 citations · Janis Taube

5. Disparities in dermatology AI performance on a diverse, curated clinical image set.

   Science advances · 2022 · 270 citations · Roberto Novoa, Elizabeth Bailey

6. Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.

   The New England journal of medicine · 2024 · 183 citations · Philip Bulterys